Surmodics, Inc. SRDX has been gaining on the back of its solid prospects in the thrombectomy business over the past few months. A robust third-quarter fiscal 2022 performance and consistent efforts to ...
On February 3, 2025, Surmodics announced the successful early clinical use of the Pounce™ XL Thrombectomy System, which is intended for removal of thrombi and emboli from peripheral arteries ranging ...
Analysis of the all-comers PROWL Registry demonstrated high procedural success and safety in a cohort reflecting the real-world complexity of patients with symptomatic limb ischemia, over 40% of whom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results